🚀
Enjoy a 7-Day Free Trial Thru Nov 06, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Strategies Created by Users
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Canadian Insider
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
Instant Alerts
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruAI
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
All Topics
General Discussions
Investment Ideas
Strategies
Article Comments
Books
Feedback
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
bluebird bio Inc (NAS:BLUE)
Transcripts
bluebird bio Inc (NAS:BLUE)
$ 0.4918
-0.0028 (-0.57%)
Market Cap: 95.37 Mil
Enterprise Value: 342.75 Mil
PE Ratio: 0
PB Ratio: 1.82
GF Score: 23/100
0
Summary
30-Y Financials
Forecast
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
bluebird bio Inc (BLUE) Transcripts
Q2 2024 bluebird bio Inc Earnings Call Transcript
Aug 14, 2024
$0.8149
(-23.12%)
Earnings
Show Key Points
Q4 2023 bluebird bio Inc Earnings Call Transcript
Mar 26, 2024
$1.2
(-11.76%)
Earnings
bluebird bio Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Q3 2023 bluebird bio Inc Earnings Call Transcript
Nov 07, 2023
$3.54
(+7.27%)
Earnings
bluebird bio Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 bluebird bio Inc Earnings Call Transcript
Aug 08, 2023
$3.89
(+8.06%)
Earnings
bluebird bio Inc at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023
bluebird bio Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023
Q4 2022 bluebird bio Inc Earnings Call Transcript
Mar 29, 2023
$3.26
(-24.54%)
Earnings
bluebird bio Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
bluebird bio Inc at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022
bluebird bio Inc Receives FDA Accelerated Approval for SKYSONA Call Transcript
Sep 19, 2022
bluebird bio Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
bluebird bio Inc Launch Call Transcript
Aug 18, 2022
bluebird bio Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
bluebird bio Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
bluebird bio Inc Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US Investor Call Transcript
Apr 05, 2022
bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
bluebird bio Inc Spotlight on bb1111 for Sickle Cell Disease Conference Call Transcript
Nov 18, 2021
bluebird bio Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
Sep 16, 2021
bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 10, 2021
bluebird bio Inc at Wedbush PacGrow Healthcare Conference (Virtual) Transcript
Aug 11, 2021
Q2 2021 bluebird bio Inc Earnings Call Transcript
Aug 09, 2021
$11.76
(-27.45%)
Earnings
bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
bluebird bio Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021
bluebird bio Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021
bluebird bio Inc to Provide Updated Findings from Reported Case of Acute Myeloid Leukemia (AML) in LentiGlobin for Sickle Cell Disease (SCD) Gene Therapy Program - Conference Call Transcript
Mar 10, 2021
bluebird bio Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 03, 2021
bluebird bio Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 25, 2021
bluebird bio Inc Temporary Suspension On Phase 1/2 And Phase 3 Studies Of LentiGlobin Gene Therapy For Sickle Cell Disease (bb1111) Corporate Call Transcript
Feb 16, 2021
bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
bluebird bio Inc to Separate Oncology Business into Independent Company Conference Call Transcript
Jan 11, 2021
bluebird bio Inc ASH Data Review Conference Call Transcript
Dec 08, 2020
bluebird bio Inc at Barclays Virtual Gene Editing & Gene Therapy Summit Transcript
Nov 16, 2020
bluebird bio Inc at Cowen Immuno-Oncology Next Summit Transcript
Nov 13, 2020
Q3 2020 bluebird bio Inc Earnings Call Transcript
Nov 04, 2020
$37.9
(+7.33%)
Earnings
bluebird bio Inc at Jefferies Cell Therapy Summit Transcript
Oct 06, 2020
bluebird bio Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Sep 18, 2020
bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2020
bluebird bio Inc at Wells Fargo Virtual Healthcare Conference Transcript
Sep 10, 2020
bluebird bio Inc at Canaccord Genuity Growth Conference (Virtual) Transcript
Aug 12, 2020
bluebird bio Inc Annual Shareholders Meeting Transcript
Jun 18, 2020
bluebird bio Inc EHA Data Review - Call Transcript
Jun 12, 2020
bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020
bluebird bio Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2020
bluebird bio Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020
bluebird bio Inc and Bristol-Myers Squibb Co to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call Transcript
May 13, 2020
Bristol-Myers Squibb Co and bluebird bio Inc to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call Transcript
May 13, 2020
Q1 2020 bluebird bio Inc Earnings Call Transcript
May 11, 2020
$38.99
(+1.60%)
Earnings
bluebird bio Inc Provides Assessment of Impact of COVID-19 - Call Transcript
Mar 26, 2020
bluebird bio Inc at Cowen HealthCare Conference Transcript
Mar 03, 2020
bluebird bio Inc at Leerink Global Healthcare Conference Transcript
Feb 26, 2020
bluebird bio Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
bluebird bio Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Transcript
Jan 09, 2020
bluebird bio Inc American Society of Hematology (ASH) Data Review - Call Transcript
Dec 10, 2019
bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa Transcript
Oct 02, 2019
bluebird bio Inc at Morgan Stanley Healthcare Conference Transcript
Sep 11, 2019
bluebird bio Inc at Citi Biotech Conference Transcript
Sep 04, 2019
bluebird bio Inc to Present New Data at the European Hematology Association (EHA) Congress Conference Call Transcript
Jun 14, 2019
bluebird bio Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019
bluebird bio Inc at Jefferies Healthcare Conference Transcript
Jun 04, 2019
bluebird bio Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
bluebird bio Inc Analyst Day Transcript
May 09, 2019
bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean - PLENARY SESSION: COMMERCIAL STRATEGIES FROM PATHFINDERS IN THE INDUSTRY Transcript
Apr 23, 2019
bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day Transcript
Mar 21, 2019
bluebird bio Inc at Barclays Global Healthcare Conference Transcript
Mar 14, 2019
bluebird bio Inc at Cowen Health Care Conference Transcript
Mar 12, 2019
1